```html

Ubra (Hair Loss on Scalp)

What is Ubra (hair loss on scalp)?

“Ubra” is a colloquial term used in several African and Caribbean communities to describe hair loss that occurs on the scalp. Medically, the condition falls under the broader category of alopecia. It can range from a few scattered thinning patches to extensive baldness. While the word “ubra” itself is not used in scientific literature, the underlying mechanisms, risk factors, and treatment options are well‑documented in dermatology.

Hair loss on the scalp may be temporary or permanent, and it can affect anyone regardless of age, gender, or ethnicity. Understanding whether the loss is due to a reversible factor (e.g., nutritional deficiency) or a progressive disorder (e.g., androgenetic alopecia) is essential for choosing an appropriate management plan.

Common Causes

The scalp is a dynamic organ that reacts to hormonal changes, inflammation, infection, mechanical stress, and genetic signals. Below are the most frequently encountered causes of scalp hair loss:

• Androgenetic alopecia (pattern hair loss) – the most common type, driven by genetic susceptibility and the hormone dihydrotestosterone (DHT). Affects both men (often receding hairline) and women (diffuse thinning).
• Alopecia areata – an autoimmune condition that produces round, smooth patches of sudden hair loss.
• Telogen effluvium – a temporary shedding that follows a physical or emotional stressor, severe illness, surgery, or rapid weight loss.
• Scarring (cicatricial) alopecia – inflammation that destroys hair follicles and replaces them with scar tissue; causes include lupus, lichen planopilaris, and dissecting cellulitis.
• Fungal infections (tinea capitis) – common in children; causes itching, scaling, and patchy baldness.
• Hair‑care practices – tight braids, ponytails, hair extensions, or harsh chemicals can produce traction alopecia or chemical‑induced loss.
• Nutritional deficiencies – iron, zinc, biotin, protein, and vitamin D deficiencies can impair hair growth.
• Hormonal disorders – thyroid disease, polycystic ovary syndrome (PCOS), and menopause can trigger diffuse thinning.
• Medications & medical treatments – chemotherapy, anticoagulants, retinoids, beta‑blockers, and high‑dose steroids may cause shedding.
• Auto‑inflammatory skin diseases – conditions such as psoriasis and seborrheic dermatitis can lead to localized hair loss if untreated.

Associated Symptoms

Hair loss rarely occurs in isolation. The presence of additional signs can help clinicians narrow the cause:

• Scaly, itchy scalp → suggests seborrheic dermatitis or fungal infection.
• Red or painful patches → points to inflammatory or autoimmune scalp disorders.
• Sudden, patchy loss with “exclamation‑point” hairs → classic for alopecia areata.
• Generalized fatigue, cold intolerance, weight changes → may indicate thyroid dysfunction.
• Acne, hirsutism, menstrual irregularities → clues to PCOS or other hormonal imbalances.
• History of recent fever, surgery, or major life stress → typical of telogen effluvium.
• Scarring, loss of skin elasticity, or “pitted” lesions → suggest cicatricial alopecia.

When to See a Doctor

Most forms of hair loss are not emergencies, but early evaluation improves outcomes. Seek professional care if you notice any of the following:

• Rapid loss of more than 50 % of scalp hair within a few weeks.
• Hair loss accompanied by pain, severe itching, swelling, or oozing.
• Patchy baldness with visible scaling, crusting, or discoloration.
• Signs of an underlying systemic disease (e.g., unexplained weight loss, fever, fatigue).
• Persistent shedding for more than six months despite lifestyle changes.
• Sudden hair loss after starting a new medication or supplement.

Diagnosis

Diagnosing scalp alopecia involves a stepwise approach that combines history‑taking, physical examination, and targeted investigations.

1. Detailed Medical History

• Onset, pattern, and speed of hair loss.
• Family history of baldness or autoimmune disease.
• Recent illnesses, surgeries, major stressors, or medication changes.
• Dietary habits, supplement use, and hair‑care practices.
• Associated systemic symptoms (fatigue, menstrual changes, etc.).

2. Physical Examination

• Inspection of scalp pattern (diffuse vs. patchy, presence of scars).
• Dermatoscopic (trichoscopic) evaluation to visualize hair shaft diameter, follicular openings, and “exclamation‑point” hairs.
• Check for skin signs elsewhere (e.g., nail pitting, rash).

3. Laboratory Tests (when indicated)

• Complete blood count (CBC) – rule out anemia.
• Serum ferritin, iron, total iron‑binding capacity – assess iron stores.
• Thyroid‑stimulating hormone (TSH) and free T4 – screen for hypo‑/hyperthyroidism.
• Vitamin D, zinc, and biotin levels if nutritional deficiency is suspected.
• Autoimmune panel (ANA, anti‑DNA) for suspected lupus or other systemic autoimmune disease.

4. Scalp Biopsy

When the diagnosis remains uncertain—particularly for scarring alopecia—a 4‑mm punch biopsy (often two samples: one for routine histology, another for special stains) is the gold standard.

5. Microbial Studies

• KOH preparation or fungal culture for suspected tinea capitis.
• Bacterial culture if there is purulent drainage.

Treatment Options

Treatment is individualized based on the underlying cause, severity, patient age, and preferences. Below is a summary of the most evidence‑based interventions.

Medical Therapies

• Androgenetic alopecia
  • Topical minoxidil 2‑5% – FDA‑approved for both men and women; promotes follicular enlargement and prolongs the growth phase. Typical response appears after 3–6 months.
  • Oral finasteride 1 mg – 5‑α‑reductase inhibitor for men; reduces DHT levels. Not recommended for women of child‑bearing potential.
  • Spironolactone 50–100 mg – Anti‑androgen used off‑label in women; benefits those with PCOS‑related hair loss.
  • Low‑level laser therapy (LLLT) – FDA‑cleared devices that may stimulate cellular metabolism.
• Alopecia areata
  • Intralesional corticosteroids (triamcinolone acetonide) – first‑line for limited patches.
  • Topical sensitizers (diphenylcyclopropenone, squaric acid dibutyl ester) – for extensive disease.
  • Oral Janus kinase (JAK) inhibitors (tofacitinib, ritlecitinib) – emerging therapies with promising trial data (NIH 2023).
• Telogen effluvium
  • Address precipitating factor (stress management, treat anemia, adjust medication).
  • Supplementation with iron (if ferritin <30 µg/L) and vitamin D as needed.
• Scarring (cicatricial) alopecia
  • High‑potency topical corticosteroids or intralesional steroids.
  • Systemic agents: oral steroids (short course), hydroxychloroquine, methotrexate, or mycophenolate – chosen based on disease pattern.
  • Early treatment is critical to prevent permanent follicular loss.
• Fungal infection (tinea capitis)
  • Oral griseofulvin 10–20 mg/kg/day for 6–8 weeks (children).
  • Terbinafine or itraconazole as alternatives for resistant strains.
  • Adjunctive antifungal shampoo (ketoconazole 2 %) to reduce spore transmission.
• Hair‑care‑related alopecia
  • Modify styling: avoid tight braids, heat, chemical relaxers.
  • Use gentle, sulfate‑free shampoos; limit use of harsh dyes.
• Nutritional deficiencies
  • Iron supplementation (ferrous sulfate 325 mg PO daily) if ferritin low.
  • Biotin 5 mg daily, zinc gluconate 30 mg, or vitamin D 2000 IU as indicated.

Home & Lifestyle Strategies

• Maintain a balanced diet rich in lean protein, leafy greens, nuts, and fatty fish (omega‑3).
• Practice stress‑reduction techniques (mindfulness, yoga, regular exercise).
• Gentle scalp massage for 5‑10 minutes daily to improve local circulation.
• Avoid smoking and limit excessive alcohol, both of which can impair follicular blood flow.
• Use a soft‑bristle brush and limit hair‑drying heat to <150 °F.

Prevention Tips

While not all hair loss can be prevented, the following measures can reduce the risk of many common forms:

• Regular health checks – yearly CBC, ferritin, and thyroid panel, especially for women of reproductive age.
• Gentle hair‑care routine – limit tight hairstyles, avoid daily harsh chemical treatments.
• Protect scalp from UV – wear a hat or use a sunscreen‑containing scalp spray when outdoors for prolonged periods.
• Prompt treatment of scalp infections – seek care at the first sign of itching, scaling, or redness.
• Balanced nutrition – include iron‑rich foods (red meat, lentils), zinc (pumpkin seeds), and vitamin D (fortified dairy, sunlight exposure).
• Stress management – chronic stress can trigger telogen effluvium; consider counseling or relaxation programs.
• Medication review – discuss any new drug’s side‑effects with a pharmacist or physician, especially for long‑term steroids or anticoagulants.

Emergency Warning Signs

Bottom Line

Ubra—or scalp hair loss—is a multifactorial condition that can signal anything from a harmless, temporary shedding episode to a progressive autoimmune disease. Early recognition of patterns, associated symptoms, and risk factors enables timely evaluation and targeted therapy. While many cases respond to topical agents, lifestyle adjustments, and nutritional optimization, some require systemic medication or even procedural interventions. If you notice unusual or rapidly progressing hair loss, especially with pain, inflammation, or systemic signs, schedule an appointment with a dermatologist or primary‑care provider without delay.

For further reading, consult reputable sources such as the Mayo Clinic, the CDC, the NIH, the World Health Organization, and the Cleveland Clinic for evidence‑based guidance.

```